The value of admission HbA 1c level in diabetic patients with acute coronary syndrome

Clinical Cardiology

Volumn 34, Issue 8, 2011, Pages 507-512

  Chan, Chi Yuen ^a   Li, Ruijie ^a   Chan, Joseph Yat Sun ^a   Zhang, Qing ^b,c   Chan, Chin Pang ^a   Dong, Ming ^a   Yan, Bryan P ^a   Lam, Yat Yin ^a   Yu, Cheuk Man ^a  

^a Division of Cardiology   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DIABETIC DIET; DIABETIC PATIENT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART ARREST; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROSPECTIVE STUDY; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHINA; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; FEMALE; HEART DISEASES; HEMOGLOBIN A, GLYCOSYLATED; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PATIENT READMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 80051548756     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20915     Document Type: Article

References (22)

1. Kannel WB, McGee DL., Diabetes and cardiovascular disease: the Framingham Study. JAMA. 1979; 241: 2035-2038. (Pubitemid 9228506)
2. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993; 16: 434-444. (Pubitemid 23046633)
3. Behar S, Boyko V, Reicher-Reiss H, et al. Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes: Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am Heart J. 1997; 133: 290-296.
4. Rydén L, Strandl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force of Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007; 28: 88-136. (Pubitemid 46137814)
5. Wahab NN, Cowden EA, Pearce NJ, et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002; 40: 1748-1754. (Pubitemid 35341952)
6. Schiele F, Descotes-Genon V, Seronde MF, et al. Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction. Diabet Med. 2006; 23: 1370-1376. (Pubitemid 44787803)
7. Aronson D, Hammerman H, Kapeliovich MR, et al. Fasting glucose in acute myocardial infarctionâ: incremental value for long-term mortality and relationship with left ventricular systolic function. Diabetes Care. 2007; 30: 960-966. (Pubitemid 46556593)
8. Ainla T, Barburin A, Teesalu R, et al. The association between hyperglycemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med. 2005; 22: 1321-1325. (Pubitemid 41391305)
9. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005; 111: 3078-3086. (Pubitemid 40847785)
10. Dziewierz A, Giszterowicz D, Siudak Z, et al. Impact of admission glucose level and presence of diabetes mellitus on mortality in patients with non-ST-segment elevation acute coronary syndrome treated conservatively. Am J Cardiol. 2009; 103: 954-958.
11. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000; 355: 773-778. (Pubitemid 30128815)
12. Cakmak M, Cakmak N, Cetemen S, et al. The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction. Can J Cardiol. 2008; 24: 375-378. (Pubitemid 351877356)
13. Hadjadj S, Coisne D, Mauco G, et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med. 2005; 22: 509-510.
14. Timmer JR, Ottervanger JP, Bilo HJ, et al. Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes. QJM. 2006; 99: 237-243.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33: S62-S69.
16. Patel MR, Dehmer GJ, Hirshfeld JW, et al. 2009 ACCF/SCAI/ STS/AATS/AHA/ASNC Appropriateness Criteria for Coronary Revascularization. J Am Coll Cardiol. 2009; 53: 530-553.
17. Lavi S, Kapeliovich M, Gruberg L, et al. Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: impact on long-term prognosis. Int J Cardiol. 2008; 123: 117-122. (Pubitemid 350250888)
18. Sinnaeve PR, Steg PG, Fox KA, et al. GRACE Investigators. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes. Arch Intern Med. 2009; 169: 402-409.
19. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-986.
20. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005; 353: 2643-2653.
21. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-853.
22. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359: 1577-1589.